ImmuneOncia Therapeutics, Inc. (KOSDAQ:424870)
11,020
+630 (6.06%)
At close: Dec 5, 2025
| Market Cap | 817.30B |
| Revenue (ttm) | 715.75M |
| Net Income (ttm) | -20.52B |
| Shares Out | 74.17M |
| EPS (ttm) | -306.75 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 12,758,133 |
| Average Volume | 12,991,219 |
| Open | 10,210 |
| Previous Close | 10,390 |
| Day's Range | 10,200 - 11,950 |
| 52-Week Range | 4,455 - 11,950 |
| Beta | n/a |
| RSI | 74.65 |
| Earnings Date | n/a |